title: ESVS Guidelines: Section A--prevention in patients with carotid stenosis.
abstract: Herein, we present the European Society for Vascular Surgery Guidelines pertinent to the secondary prevention of cerebrovascular events in patients with carotid artery stenosis including lipid lowering therapy, antiplatelet therapy and other risk factor modification. These recommendations are based on current evidence from clinical trials. There is a need for aggressive prevention treatment in patients with carotid artery disease. We also discuss the diagnosis and grading of carotid artery stenosis.
authors.affiliation: Department of Vascular Surgery, Athens University Medical School, Attikon University Hospital, Athens, Greece. liapis@med.uoa.gr
authors.forename: Christos D
authors.initials: CD
authors.lastname: Liapis
authors.forename: Peter F
authors.initials: PF
authors.lastname: Bell
authors.forename: Dimitri P
authors.initials: DP
authors.lastname: Mikhailidis
authors.forename: Juhani
authors.initials: J
authors.lastname: Sivenius
authors.forename: Andrew
authors.initials: A
authors.lastname: Nicolaides
authors.forename: Jose
authors.initials: J
authors.lastname: Fernandes e Fernandes
authors.forename: Giorgio
authors.initials: G
authors.lastname: Biasi
authors.forename: Lars
authors.initials: L
authors.lastname: Norgren
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use; D016893:Carotid Stenosis / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology* / Q000628:therapy; D002561:Cerebrovascular Disorders / Q000097:blood / Q000453:epidemiology* / Q000517:prevention & control* / Q000628:therapy; D008078:Cholesterol, LDL; D000075202:Contraindications; D016903:Drug Monitoring; D004359:Drug Therapy, Combination / Q000009:adverse effects; D006801:Humans; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D012307:Risk Factors
chemical_list: D000959:Antihypertensive Agents; D008078:Cholesterol, LDL; D000960:Hypolipidemic Agents; D010975:Platelet Aggregation Inhibitors